[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100468971":3},{"organization":4,"armGroups":7,"interventions":21,"overallOfficials":62,"centralContacts":66,"locations":75,"responsibleParty":92,"collaborators":94,"id":97,"slug":26,"hasResults":98,"nctId":99,"briefTitle":100,"officialTitle":101,"acronym":26,"eligibilityCriteria":102,"healthyVolunteers":98,"sex":103,"minAge":104,"maxAge":26,"enrollmentInfo":105,"targetDuration":26,"studyType":108,"phases":109,"briefSummary":111,"conditions":112,"keywords":115,"overallStatus":77,"whyStopped":26,"lastUpdateSubmitDate":117,"lastUpdatePostDateStruct":118,"startDateStruct":121,"completionDateStruct":123,"leadSponsor":125,"locationsCount":126},{"fullName":5,"class":6},"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","OTHER",[8],{"label":9,"type":6,"description":10,"interventionNames":11},"Early stage breast cancer survivors","Patients with history of early stage breast cancer and at least 3 months from completion of local and systemic therapy at Johns Hopkins",[12,13,14,15,16,17,18,19,20],"Other: Prescreening","Other: Screening and Enrollment","Behavioral: Baseline","Behavioral: Interpret BMI","Other: Interpret HbA1c","Other: Interpret lipid panel and assess other risk factors","Behavioral: Assess 10 year risk of cardiovascular event","Behavioral: Recommendations","Behavioral: Follow-Up",[22,27,31,38,42,46,50,54,58],{"type":6,"name":23,"description":24,"armGroupLabels":25,"otherNames":26},"Prescreening","Eligible patients (history of early stage breast cancer and at least 3 months from completion of local and systemic therapy at Johns Hopkins, reads and speaks English) complete survey for demographics, smoking status \\& questions about cardiovascular disease.",[9],null,{"type":6,"name":28,"description":29,"armGroupLabels":30,"otherNames":26},"Screening and Enrollment","Consent",[9],{"type":32,"name":33,"description":34,"armGroupLabels":35,"otherNames":36},"BEHAVIORAL","Baseline","Behavioral Battery and Patient Reported Outcome Quality of Life questionnaires (EORTC QLQ-C30 and QLQ-BR23) Labs (Hba1c + lipid panel if not done within 12 months or if abnormal within 1 year) Abstract vitals from chart review",[9],[37],"Patient- reported outcomes questionnaires, labs, vitals results",{"type":32,"name":39,"description":40,"armGroupLabels":41,"otherNames":26},"Interpret BMI","Refer to Healthful Eating, Activity and Weight Program (HEAWP) if BMI ≥25 and not already on lifestyle intervention",[9],{"type":6,"name":43,"description":44,"armGroupLabels":45,"otherNames":26},"Interpret HbA1c","HbA1c results categorized as follows:\n\nHbA1c \\\u003C5.7%; HbA1c 5.7-6.4%; HbA1c 6.5%+; or Known diabetic on medication",[9],{"type":6,"name":47,"description":48,"armGroupLabels":49,"otherNames":26},"Interpret lipid panel and assess other risk factors","Based on above categories:\n\nHbA1c \\\u003C5.7%: Any of these cardiovascular disease risk factors: current\u002Fformer tobacco use, total cholesterol \\>200, family history of Coronary Artery Disease\u002FHeart Attack in first degree family \\\u003C55 year old male or \\\u003C65 year old female, systolic blood pressure \\>130 HbA1c 5.7-6.4%: Refer to Primary Care Provider and consider Healthful Eating, Activity and Weight Program (HEAWP) HbA1c 6.5%+: Refer to Endocrinology if HbA1c ≥8% Known diabetic on medication: Refer to Endocrinology if HbA1c ≥7%",[9],{"type":32,"name":51,"description":52,"armGroupLabels":53,"otherNames":26},"Assess 10 year risk of cardiovascular event","If risk factors are present - refer to Cardiovascular Disease Prevention Program",[9],{"type":32,"name":55,"description":56,"armGroupLabels":57,"otherNames":26},"Recommendations","Provide individual patient handout based on all above interventions",[9],{"type":32,"name":59,"description":60,"armGroupLabels":61,"otherNames":26},"Follow-Up","6 and 12 month labs (if prior abnormal) and Patient Reported Outcome questionnaires",[9],[63],{"name":64,"affiliation":5,"role":65},"Jennifer Sheng, M.D.","PRINCIPAL_INVESTIGATOR",[67,72],{"name":68,"role":69,"phone":70,"phoneExt":26,"email":71},"Hopkins Breast Trials","CONTACT","410-614-1361","HopkinsBreastTrials@jhmi.edu",{"name":5,"role":69,"phone":73,"phoneExt":26,"email":74},"410-955-8804","jhcccro@jhmi.edu",[76],{"facility":5,"status":77,"city":78,"state":79,"zip":80,"country":81,"cosmosGeoPoint":82,"geoPoint":87,"contacts":88},"RECRUITING","Baltimore","Maryland","21231-1000","United States",{"type":83,"coordinates":84},"Point",[85,86],-76.61219,39.29038,{"lat":86,"lon":85},[89],{"name":90,"role":69,"phone":91,"phoneExt":26,"email":26},"Vered Stearns, MD","443-287-6547",{"type":93,"investigatorFullName":26,"investigatorTitle":26,"investigatorAffiliation":26,"oldNameTitle":26,"oldOrganization":26},"SPONSOR",[95],{"name":96,"class":6},"Private Philanthropic Funds","100468971",false,"NCT05386719","Cardiometabolic Screening Program","A Cardiometabolic Screening Program for Breast Cancer Survivors","Inclusion Criteria:\n\n* Diagnosis of early stage breast cancer\n* Completed local and\u002For systemic therapy at least 3 months ago\n* Receiving medical oncology care at through the breast cancer clinics at Johns Hopkins Medical Institute, including the Sidney Kimmel Comprehensive Cancer Center in Baltimore MD and Green Spring Station in Lutherville-Timonium MD, and Sibley Memorial Hospital in Washington D.C.\n* Read and speak English\n\nExclusion Criteria:\n\n* Metastatic breast cancer","ALL","18 Years",{"count":106,"type":107},450,"ESTIMATED","INTERVENTIONAL",[110],"NA","This research study is being done to implement a screening program for prediabetes, diabetes, dyslipidemia and\u002For hyperlipidemia, and higher risk of cardiovascular disease in breast cancer survivors. This program will also help to direct individuals with risk factors to community and institutional resources for management.",[113,114],"Breast Cancer","Early-stage Breast Cancer",[116],"Survivor","2026-06-22",{"date":119,"type":120},"2026-06-25","ACTUAL",{"date":122,"type":120},"2022-06-03",{"date":124,"type":107},"2027-08-01",{"name":5,"class":6},1]